Tamiflu-Like Pill Shows Efficacy Against COVID-19 Illness and Death

The American pharmaceutical company, Merck, announced its medication, molnupiravir, decreased hospitalizations and deaths by 50% among individuals with COVID-19. The pill, which is taken twice daily for 5 days, would be the first exclusively designed to fight COVID-19. The medication hinders the ability of SARS-CoV-2 to reproduce. Public health experts have longed for this type of treatment, similar to how Tamiflu reduces the severity of the flu, as an important tool in mitigating the global pandemic. Click here to read more.